Ranolazine exhibits anti-inflammatory and antioxidant activities in H9c2 cardiomyocytes.
Sign Up to like & getrecommendations! Published in 2023 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202304_31927
Abstract: OBJECTIVE The aim of this study was to evaluate the effectiveness of ranolazine on hypoxia-inducible factor-1α (HIF-1α) and oxidative stress in H9c2 cardiomyocyte cells. MATERIALS AND METHODS We have assessed the effects of increasing concentrations… read more here.
Keywords: oxidative stress; antioxidant capacity; markers decreased; h9c2 cardiomyocytes ... See more keywords